FEDERATED HERMES, INC. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 103 filers reported holding REVANCE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.7%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$444,899
+172.8%
38,788
+502.0%
0.00%
Q2 2023$163,072
-75.7%
6,443
-82.3%
0.00%
-100.0%
Q4 2022$670,135
-74.2%
36,302
-62.2%
0.00%
-75.0%
Q3 2022$2,595,000
+54.7%
96,146
-20.8%
0.01%
+60.0%
Q2 2022$1,677,000
-19.5%
121,400
+44.9%
0.01%0.0%
Q3 2018$2,083,000
-5.3%
83,810
+4.6%
0.01%
-16.7%
Q2 2018$2,200,000
+22.1%
80,130
+36.9%
0.01%
+20.0%
Q1 2018$1,802,000
+31.6%
58,530
+52.9%
0.01%
+25.0%
Q4 2017$1,369,000
-1.2%
38,285
-23.9%
0.00%0.0%
Q3 2017$1,385,000
+162.3%
50,285
+151.4%
0.00%
+100.0%
Q2 2017$528,000
+26.6%
20,000
-0.3%
0.00%
+100.0%
Q1 2017$417,000
+0.7%
20,051
+0.3%
0.00%0.0%
Q4 2016$414,000
+27.8%
20,0000.0%0.00%0.0%
Q3 2016$324,000
+19.1%
20,0000.0%0.00%0.0%
Q2 2016$272,000
-22.1%
20,0000.0%0.00%0.0%
Q1 2016$349,000
-48.9%
20,0000.0%0.00%
-50.0%
Q4 2015$683,000
-56.2%
20,000
-59.6%
0.00%
-60.0%
Q1 2014$1,559,00049,4900.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders